Brief Report: Droplet Digital Polymerase Chain Reaction Versus Plasma Next-Generation Sequencing in Detecting Clearance of Plasma EGFR Mutations and Carcinoembryonic Antigen Levels as a Surrogate Measure-Reference-Cited by-同舟云学术

Brief Report: Droplet Digital Polymerase Chain Reaction Versus Plasma Next-Generation Sequencing in Detecting Clearance of Plasma EGFR Mutations and Carcinoembryonic Antigen Levels as a Surrogate Measure

Published:2023-12 Issue:12 Volume:4 Page:100599
ISSN:2666-3643
Container-title:JTO Clinical and Research Reports
language:en
Short-container-title:JTO Clinical and Research Reports

Author:

Saw Stephanie P.L.^ORCID,Tan Gek San,Tan Wei Chong,Tan Aaron C.,Lai Gillianne G.Y.,Lim Darren W.T.,Kanesvaran Ravindran,Tan Wan Ling,Tan Sze Huey,Lim Kiat Hon,Skanderup Anders J.,Tan Daniel S.W.

Funder

National Medical Research Council

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine,Oncology

Reference11 articles.

1. Early clearance of plasma EGFR mutations as a predictor of response to osimertinib and comparator EGFR-TKIs in the FLAURA trial;Zhou;J Clin Oncol,2019

2. EGFR mutation tracking predicts survival in advanced EGFR- mutated non-small cell lung cancer patients treated with osimertinib;Buder;Transl Lung Cancer Res,2020

3. PL03.13 osimertinib with/without platinum-based chemotherapy as first-line treatment in patients with EGFRm advanced NSCLC (FLAURA2);Janne;J Thorac Oncol,2023

4. Economic analysis of Tissue-First, plasma-first, and complementary NGS approaches for treatment-naïve metastatic lung adenocarcinoma;Yang;Front Oncol,2022

5. Noninvasive detection of response and resistance in EGFR-mutant lung cancer using quantitative next-generation genotyping of cell-free plasma DNA;Oxnard;Clin Cancer Res,2014

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Real-world outcomes of pemetrexed-platinum chemotherapy plus osimertinib after progression on first-line osimertinib in advanced EGFR-mutated NSCLC;Lung Cancer;2024-07